- CFO Spotlights
- Profiles
- Christopher P. Acevedo
Profile
Christopher P. Acevedo
Chief Financial Officer (Principal Financial and Accounting Officer), OS Therapies Incorporated
Former. First published here October 28, 2026; built from records as of October 28, 2026.
OS Therapies Incorporated named Francis (Frank) Knuettel II to succeed Christopher P. Acevedo, effective September 29, 2026.2
Seats
The seat in the record
| Company | Title as filed | Standing |
|---|---|---|
| OS Therapies Incorporated (OSTX) Pharmaceutical Preparations | Chief Financial Officer (Principal Financial and Accounting Officer) | Former |
Company names link to the company's page in the record at CFO Tribune, which holds the seat history.
The record
Filing by filing, latest first
- September 29, 2026effective
OS Therapies Incorporated named Francis (Frank) Knuettel II to succeed Christopher P. Acevedo, effective September 29, 2026. Profile of Francis (Frank) Knuettel II.
[2] Filing by OS Therapies Incorporated, filed with the SEC on October 5, 2026. Read the filing. The record at CFO Tribune.
- March 31, 202610-K filed
Christopher P. Acevedo signed the annual report of OS Therapies Inc on Form 10-K as Chief Financial Officer (Principal Financial and Accounting Officer), filed March 31, 2026.
/s/ Christopher P. Acevedo Christopher P. Acevedo Chief Financial Officer (Principal Financial and Accounting Officer)
[1] Annual report on Form 10-K by OS Therapies Inc, filed with the SEC on March 31, 2026. Read the filing. The record at CFO Tribune.
Sources
Sources
- Annual report on Form 10-K, OS Therapies Inc. U.S. Securities and Exchange Commission, EDGAR, filed March 31, 2026. sec.gov; record.
- Current report filed with the SEC, OS Therapies Incorporated. U.S. Securities and Exchange Commission, EDGAR, filed October 5, 2026. sec.gov; record.
Corrections and removal
If a line here is wrong, or Christopher P. Acevedo wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.